Vulnerability · Published Jun 24, 2022 · Assigned by icscert
CVE-2022-15183.2.2 IMPROPER LIMITATION OF A PATHNAME TO A RESTRICTED DIRECTORY ('PATH TRAVERSAL') CWE-22
Critical 10.0
In plain English
A critical-severity path traversal in iSeq 100 Instrument from Illumina. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 1.7% (higher than 77% of all known vulnerabilities).
Severity (CVSS 3.1)10.0Critical
Exploit odds (30 days)1.7%top 23.1% of all CVEs
Exploited in the wildNo reportsCISA SSVC: none
Attack toolingNoneno public tooling known
Official description
LRM contains a directory traversal vulnerability that can allow a malicious actor to upload outside the intended directory structure.
Affected products (as reported)
| Vendor | Product | Versions |
|---|---|---|
| Illumina | NextSeq 550Dx | LRM Versions 1.3 to 3.1 |
| Illumina | MiSeq Dx | LRM Versions 1.3 to 3.1 |
| Illumina | NextSeq 500 Instrument | LRM Versions 1.3 to 3.1 |
| Illumina | NextSeq 550 Instrument | LRM Versions 1.3 to 3.1 |
| Illumina | MiSeq Instrument | LRM Versions 1.3 to 3.1 |
| Illumina | iSeq 100 Instrument | LRM Versions 1.3 to 3.1 |
| Illumina | MiniSeq Instrument | LRM Versions 1.3 to 3.1 |
Weakness: CWE-22 · Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
References
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-153-02 x_refsource_MISC